WPC
JAZZ icon

Wedmont Private Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wedmont Private Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Buy
2,474
+171
+7% +$37.5K 0.02% 488
2026
Q1 		$451K Buy
2,303
+18
+0.8% +$3.15K 0.01% 531
2025
Q4 		$387K Buy
2,285
+22
+1% +$3.37K 0.01% 562
2025
Q3 		$311K Buy
2,263
+262
+13% +$31.4K 0.01% 611
2025
Q2 		$223K Sell
2,001
-3,911
-66% -$425K 0.01% 691
2025
Q1 		$594K Sell
5,912
-903
-13% -$118K 0.03% 334
2024
Q4 		$827K Buy
6,815
+1,843
+37% +$217K 0.04% 265
2024
Q3 		$540K Buy
4,972
+507
+11% +$55.6K 0.03% 332
2024
Q2 		$471K Buy
4,465
+2,584
+137% +$284K 0.03% 360
2024
Q1 		$214K Buy
+1,881
New +$230K 0.02% 551

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Wedmont Private Capital's JAZZ Position: Q2 2026 in Review

Wedmont Private Capital increased its Jazz Pharmaceuticals (JAZZ) stake by 7.4% in Q2 2026, buying an estimated $37.5K and bringing the position to 2,474 shares worth $603K. The position accounts for 0.02% of the portfolio, ranked #488.

Wedmont Private Capital first reported a position in JAZZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $827K in Q4 2024. 194 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Wedmont Private Capital held 2,474 shares of Jazz Pharmaceuticals worth $603K as of Q2 2026.
  • Wedmont Private Capital bought 171 Jazz Pharmaceuticals shares in Q2 2026, an estimated $37.5K.
  • Jazz Pharmaceuticals made up 0.02% of Wedmont Private Capital's portfolio in Q2 2026, its #488 holding.
  • Wedmont Private Capital first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Wedmont Private Capital's Jazz Pharmaceuticals position peaked at $827K in Q4 2024.
  • 194 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.